Carolina Oliveira serves as the CEO and co-founder of OneSkin, a biotech company based in Silicon Valley. The company is recognized for pioneering the skin longevity category, with its proprietary peptide OS-01 clinically validated to reduce skin biological age.

Originally from Brazil, Oliveira moved to Silicon Valley in 2016 to establish OneSkin, which has since become one of the fastest-growing longevity brands. She holds a Ph.D.